A knockout mouse model gives us clues regarding the important normal functions of both full-length and secreted fragments of the ␤-amyloid precursor protein in the central nervous system.
In 1906 Alois Alzheimer examined the brain of a profoundly demented patient and observed the presence of intraneuronal fibrils (neurofibrillary tangles) and 'miliary foci of a peculiar substance in the cerebral cortex' (senile plaque). 1 Diagnosis of the disease, later named after Alzheimer, still rests on the identification of tangles and plaques in postmortem brain tissue. Although Alzheimer's disease (AD) was initially thought to be a rare disorder, it has become a serious public health issue. To understand the pathology of and to direct potential therapies for AD requires characterizing the major proteins associated with AD brain lesions. To this end, we are studying ␤-amyloid precursor protein (␤PP), the precursor to the ␤-amyloid (A␤) that is the major protein constituent of AD senile plaques.
Because ␤PP is abundantly expressed in brain cells and because potential therapeutic strategies are aimed at altering ␤PP levels it is important to determine the physiological role of ␤PP in brain. Although many putative roles have been attributed to ␤PP (recently reviewed in Reference 2), 2 it is crucial to determine if diminishing ␤PP affects normal neuronal physiology. A mouse model that is deficient in ␤PP has been developed and exhibits phenotypic abnormalities including: reactive gliosis, a reduced forelimb grip strength, and decreased locomotion. 3 While the reasons underlying the phenotypic changes in the ␤PP-deficient mice have not been thoroughly explored, the model does argue that ␤PP is important for normal nervous system function. We began our investigations to determine the biology of neuronal ␤PP and have recently shown that ␤PP contributes to neuronal viability and neuron differentiation in vitro. 4 By comparing the survival of cultured hippocampal neurons from wild-type (WT) and ␤PP-deficient knockout (KO) mice, we determined that WT neurons survive better than do KO neurons in all culture conditions tested.
Correspondence: RG Perez, PhD, Allegheny University of the Health Sciences, Center for Neuroscience Research, 10th Floor, South Tower, 320 E North Avenue, Pittsburgh, PA 15212, USA Because WT neurons express full-length ␤PP while KO neurons do not, and because the presence of different factors in the media did not rescue KO neurons to the same level as WT controls, it appears that neuron survival is enhanced by the expression of cell-associated full-length ␤PP.
The advantage of using this unique model system is that it allows for selectively teasing apart the relative contributions of cell-associated ␤PP, on neurons, from the effects of soluble forms of ␤PP. To test for differences in process outgrowth in response to astrocytederived soluble factors we co-cultured WT and KO neurons with astrocytes obtained from WT or KO mice. WT (but not KO) astrocytes release soluble ␤PP fragments 5 including the long N-terminal fragments (referred to as ␤PP s ), generated by a single enzymatic cleavage of ␤PP by '␣-secretase' or '␤-secretase'. 6 Very little 4-kDa A␤ peptide is secreted from astrocytes. 5 In this co-culture system we observed that the initiation of axon outgrowth, not the ability of axons to grow, relies on ␤PP expression. Full-length ␤PP has homology to cell surface receptors and has a C-terminal Gprotein binding domain 2 which suggests that ␤PP may transduce signals from the cell surface. Because neurons retain more ␤PP as full-length molecules, 2,5 fulllength ␤PP may be important for normal neuron function. Although we have no direct evidence, it may be that ␤PP at the cell surface provides a signal to the neuron regarding which process will become the axon. In addition to our findings related to full-length ␤PP and axon growth, we observed that both WT and KO neurons grow much longer axons in the absence of soluble ␤PP fragments (ie when grown with KO astrocytes) which suggests that the long N-terminal fragments of ␤PP s may actually limit axon growth.
WT and KO neurons grown with WT astrocytes (ie in the presence of soluble ␤PP fragments) have more dendrites that are more branched. Thus, the data suggest that ␤PP s enhances arborization. Consistent with this interpretation is the finding of a report in which WT neurons exposed to added ␤PP s exhibit more dendritic growth. 7 The possibility that endogenous ␤PP s may enhance dendrite growth is further supported by in vivo data from ␤PP-deficient KO mice. KO hippocampal neurons that were labeled after electrophysiological recording, have smaller dendritic arbors than do WT controls. 8 The neurons in these in vivo experiments look similar to KO hippocampal neurons co-cultured with KO astrocytes in our studies (Figure 1) . In summary, our data suggest that ␤PP and soluble ␤PP products provide a variety of signals that initiate, promote, or maintain various aspects of neuron growth and survival.
Recent work from van Leeuwen and colleagues suggests a new twist regarding the potential importance of normal ␤PP function and AD. 9 In a novel series of experiments, they have shown that AD brains contain abnormally truncated ␤PP proteins within neurons. Their work, based on studies of mRNA editing, confirm that altered proteins result from dinucleotide deletions (⌬GA or ⌬GT) in or adjacent to GAGAG mRNA sequences. One protein analyzed was ␤PP which contains a number of GAGAG motifs in its mRNA sequence. They discovered a dinucleotide deletion in ␤PP exon 9 that changes the amino acid sequence RERMS to RENVP. Surprisingly, this pentapeptide motif is precisely the domain that was postulated to have trophic activity in ␤PP s . 10 The frameshift mutation that eliminates the RERMS sequence also produces a truncated ␤PP protein due to the formation of an early 'stop' codon. 9 In the hippocampus of approximately 50% of AD and 70% of Down syndrome (DS) individuals, but in none of the controls, they observed an accumulation of mutant ␤PP proteins which they call ␤APP +1 proteins. Other brain areas important for cognition also showed increased levels of the ␤APP +1 proteins in both AD and DS brains. Taken together, the data suggest that ␤PP contributes to normal neuronal function in brain and that the loss of ␤PP trophic function may be related to AD. The ␤PP-deficient KO mouse model should be useful for further evaluating ␤PP function both in vivo and in vitro. Tract tracing studies should reveal whether the mice have altered axon and dendritic growth. In vitro analyses of secreted ␤PP fragments should delineate their potential contributions to axon and dendritic growth on neurons and may clarify whether secreted ␤PPs interact with full-length ␤PP at the cell surface. Such studies should further our understanding of how ␤PP contributes to both wellness and disease.
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